Ryman Healthcare Limited (NZE: RYM)
New Zealand
· Delayed Price · Currency is NZD 5.00
+0.15 (3.09%)
Nov 21, 2024, 5:00 PM NZST
Ryman Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 650.53 | 650.53 | 560.11 | 503.76 | 452.41 | 422.11 | Upgrade
|
| Other Revenue | 37.03 | 37.03 | 21.5 | 5 | 3.28 | 1.23 | Upgrade
|
| Revenue | 687.56 | 687.56 | 581.61 | 508.76 | 455.69 | 423.34 | Upgrade
|
| Revenue Growth (YoY) | 18.22% | 18.22% | 14.32% | 11.64% | 7.64% | 10.88% | Upgrade
|
| Cost of Revenue | 651.88 | 651.88 | 542.16 | 466.24 | 395.31 | 349.25 | Upgrade
|
| Gross Profit | 35.68 | 35.68 | 39.45 | 42.52 | 60.39 | 74.09 | Upgrade
|
| Operating Expenses | 43.8 | 43.8 | 37.72 | 35.7 | 32.37 | 28.62 | Upgrade
|
| Operating Income | -8.13 | -8.13 | 1.74 | 6.82 | 28.02 | 45.47 | Upgrade
|
| Interest Expense | -70.33 | -70.33 | 3.91 | -30.66 | -19.37 | -19.31 | Upgrade
|
| Interest & Investment Income | 2.33 | 2.33 | 2.14 | 0.04 | 0.1 | 0.55 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -24.41 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -5.95 | -5.95 | -197.66 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -82.07 | -82.07 | -214.27 | -23.8 | 8.76 | 26.71 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -15.1 | - | Upgrade
|
| Asset Writedown | -64.03 | -64.03 | 420.47 | 745.89 | 416.85 | 144.44 | Upgrade
|
| Other Unusual Items | 1.18 | 1.18 | - | - | - | - | Upgrade
|
| Pretax Income | -144.93 | -144.93 | 206.2 | 722.08 | 410.5 | 171.15 | Upgrade
|
| Income Tax Expense | -149.7 | -149.7 | -51.64 | 29.21 | -12.56 | -93.56 | Upgrade
|
| Net Income | 4.78 | 4.78 | 257.84 | 692.87 | 423.06 | 264.71 | Upgrade
|
| Net Income to Common | 4.78 | 4.78 | 257.84 | 692.87 | 423.06 | 264.71 | Upgrade
|
| Net Income Growth | -98.15% | -98.15% | -62.79% | 63.78% | 59.82% | -18.80% | Upgrade
|
| Shares Outstanding (Basic) | 688 | 688 | 516 | 500 | 500 | 500 | Upgrade
|
| Shares Outstanding (Diluted) | 688 | 688 | 516 | 500 | 500 | 500 | Upgrade
|
| Shares Change (YoY) | 33.18% | 33.18% | 3.26% | - | - | - | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | 0.50 | 1.39 | 0.85 | 0.53 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | 0.50 | 1.39 | 0.85 | 0.53 | Upgrade
|
| EPS Growth | -98.61% | -98.61% | -63.96% | 63.78% | 59.82% | -18.80% | Upgrade
|
| Free Cash Flow | 394.06 | 394.06 | 219.01 | 251.68 | 156.52 | 149.7 | Upgrade
|
| Free Cash Flow Per Share | 0.57 | 0.57 | 0.42 | 0.50 | 0.31 | 0.30 | Upgrade
|
| Dividend Per Share | - | - | 0.088 | 0.224 | 0.224 | 0.242 | Upgrade
|
| Dividend Growth | - | - | -60.71% | 0% | -7.44% | 6.61% | Upgrade
|
| Gross Margin | 5.19% | 5.19% | 6.78% | 8.36% | 13.25% | 17.50% | Upgrade
|
| Operating Margin | -1.18% | -1.18% | 0.30% | 1.34% | 6.15% | 10.74% | Upgrade
|
| Profit Margin | 0.69% | 0.69% | 44.33% | 136.19% | 92.84% | 62.53% | Upgrade
|
| Free Cash Flow Margin | 57.31% | 57.31% | 37.66% | 49.47% | 34.35% | 35.36% | Upgrade
|
| EBITDA | 15.83 | 15.83 | 24.34 | 34.74 | 52.77 | 68.69 | Upgrade
|
| EBITDA Margin | 2.30% | 2.30% | 4.18% | 6.83% | 11.58% | 16.23% | Upgrade
|
| D&A For EBITDA | 23.96 | 23.96 | 22.6 | 27.92 | 24.76 | 23.22 | Upgrade
|
| EBIT | -8.13 | -8.13 | 1.74 | 6.82 | 28.02 | 45.47 | Upgrade
|
| EBIT Margin | -1.18% | -1.18% | 0.30% | 1.34% | 6.15% | 10.74% | Upgrade
|
| Effective Tax Rate | - | - | - | 4.05% | - | - | Upgrade
|
| Revenue as Reported | 689.89 | 689.89 | 583.75 | 1,255 | 872.64 | 568.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.